Public Health Law News
October 2020
Webinar: Opioid Litigation and Its Impact
Join this webinar to be held on October 22 from 12:00–4:00 pm (EDT). The RAND Institute for Civil Justice and the RAND Kenneth R. Feinberg Center for Catastrophic Risk Management and Compensation have assembled a distinguished group of attorneys, judges, and scholars to discuss opioid litigation and how they view its impact on the future of mass litigation. Review the agenda and register.
Hiring: General Counsel (New York City)
The New York City Department of Health and Mental Hygiene is seeking a General Counsel to act as chief legal officer for the legal department, report directly to the Commissioner of Health, and advise on legal obligation and strategy initiatives for the department. Deadline for applications is December 31. Learn more about the position (search for Job ID #432735).
Fact Sheet: Data Governance Strategies for States and Tribal Nations
The Network for Public Health Law has published a fact sheet on data governance strategies for states and tribal nations. Sound and effective governance strategies for data sharing among states and tribal nations are indispensable for ensuring trust, data privacy, and security risk management. Get the fact sheet[PDF – 742KB].
Law and Policy Pathways: Equity in Birth Outcomes
This guide, published by the Network for Public Health Law, provides an overview of key law and policy measures around improved maternal and child health. The one-page conceptual guide shows a pathway to alleviate disparities in maternal morbidity and mortality and also ensure that conditions for optimal birth outcomes are present for all. View the guide.
California: Gov. Newsom signs package of bills addressing behavioral healthcare
Healthcare Innovation (09/25/2020) David Raths
Story Highlights
California Governor Gavin Newsom signed this collection of bills on September 25 intended to close gaps in behavioral health care coverage. SB 855 expands required coverage of treatment for behavioral conditions, for both mental health and substance use, creates a standard for the utilization of clinical guidelines, and establishes standards for what is “medically necessary.”
The new package of bills expands required coverage by commercial health plans and insurers, not all of which were supportive. The California Association of Health Plans believes that SB 855 “recklessly defines medical necessity in a way that will undermine the ability of providers to determine what is clinically appropriate for their patients… [it may] open the door for unlicensed providers and facilities to treat those suffering from mental health and substance use disorders, which puts vulnerable patients at risk.”
Previously, California’s state law required health plans to cover medically necessary treatment of just nine serious mental illnesses. The new law AB 1976 reforms Laura’s Law by increasing access to care for those needing outpatient behavioral health treatment while SB 855 requires health plans and insurers to cover medically necessary treatment for all mental health and substance use disorders.
California has seen other recent policy updates in substance use and mental health disorders, beyond the passage of SB 855. In January, Gov. Newsom formed the Behavioral Health Task Force, diverted Mental Health Services Act funds to accommodate substance abuse treatment (AB 2265), signed bills that support statewide behavioral health standards (SB 803), and expanded court-order outpatient treatment utilization (AB 1976).
Maine: Maine CDC to expand support for residents with Alzheimer’s and dementia, advancing age-friendly efforts
News Center Maine (09/27/2020) Erin Keller
Story Highlights
The Maine legislature passed a law (HP 036) that grants the state $200,000 to address dementia care, pursuant a federal law (Public Law 115)[PDF – 311KB]. Maine, which has the highest proportion of citizens aged over 65 of any state, will use the funds to create and expand programs to prevent dementia, including Alzheimer’s disease.
The funding, which can be renewed until 2023, will be used by governmental actors as well as non-governmental entities.
Maine is the first of 15 eligible states to receive the award.
California: In big win for wildlife, California curbs use of dangerous rat poisons
Earth Island Journal (10/01/2020) Fiona McLeod
[Editor’s note: Read the California Ecosystems Protection Act (AB 1788).]
Maryland: Maryland strengthens hate crime law as new laws take effect
The Associated Press (09/30/2020) Brian Witte
[Editor’s note: Read HB 917.]
New York: New standards to cut hydroflourocarbons finalized
Lansing Star (09/23/2020) the Office of the Governor
[Editor’s note: Read CDC resources on climate change and current sustainability goals.]
South Carolina: Charleston County 911 using in-house mental health counselor
Lowcountry Headlines (10/01/2020) Paola Tristan Arruda
National: FDA requires stronger warning label for Xanax, Valium and other benzodiazepine drugs
USA Today (09/24/2020) Adrianna Rodriguez
[Editor’s note: Read the FDA’s press release.]
National: Drug imports from Canada allowed to keep prescription costs down
Bloomberg Law (09/24/2020) Andrew Childers
[Editor’s note: Read the HHS-approved document[PDF – 516KB].]
National: Blue Cross insurers reach tentative settlement in antitrust lawsuit, source says
CNBC (09/25/2020)
China: Patent law amendment draft introduces patent linkage for pharmaceutical patents
Managing IP (09/30/2020) Xiaohui Wu
Mexico: Mexico, plagued by cartel wars, on cusp of legal cannabis ‘green rush’
Reuters (10/01/2020) Drazen Jorgic
Arizona: An Arizona district judge did not grant a federally funded irrigation company’s motion to dismiss a Native American community’s complaint. The tribe alleged that the entity supplied them with contaminated water and breached their agreement with the American government.
The Ak-Chin Tribe of Pinal County claimed that the Maricopa-Stanfield Irrigation & Drainage District, a corporation contracting with the United States, has consistently undersupplied their community with water suitable for irrigation and has instead supplied them with lower-quality groundwater, a violation of the 1984 Settlement Act. In its motion to dismiss, the defendants alleged that the Ak-Chin improperly filed the suit in a federal court without joining a necessary co-defendant, the US government. The judge did order the tribe to join the United States as a party.
Ak-Chin Indian Community v. Maricopa-Stanfield Irrigation & Drainage District
US District Court, D. Arizona
Case No. CV-20-00489-PHX-JJT
September 14, 2020
John J. Tuchi, District Judge
California: A federal court in California held that class action suit against CVS Pharmacy may proceed. The plaintiff, Danielle Lokey, representing on behalf of other potential injured parties, alleges that CVS illegally sold its store-brand liquid acetaminophen at a higher price when advertised as a formulation specifically for infants, which would be a violation of the state’s consumer protection laws.
Lokey claims that CVS deceptively marketed two identical acetaminophen products as distinct medications, one appropriate for children aged 2–11 years and one appropriate for infants, with the latter costing much more than the former.
CVS filed a motion to move the case to federal court, arguing that the store brand acetaminophen does not have state-specific packaging and any injunction requiring a change in California would affect sales nationwide. The potential costs estimated by CVS would exceed the amount required to bring the suit to federal court under California’s Class Action Fairness Act. The plaintiff challenged CVS’s motion, arguing that defendants inflated their cost estimation in order to force a change in jurisdiction.
The court held in favor of CVS, stating that the defendant provided sufficient evidence to support their estimate and that the plaintiff “did not meaningfully counter [CVS’s] assessment.”
Lokey v. CVS Pharmacy
US District Court, N.D. California, San Francisco Division
Case No. 20-cv-04782-LB
September 17, 2020
Laurel Beeler, Magistrate Judge
Ohio: An Ohio district court denied a Cleveland hospital’s motion for summary judgment regarding a discrimination suit brought by patient who is deaf. The court found that “reasonable jurors could find that [the] Defendant essentially failed to act to protect Plaintiff’s rights as a deaf person,” adding that the jury could find “an element of deliberateness” to the alleged discrimination.
In May 2018, plaintiff Alicia Tokmenko sustained life-threatening injuries in a motor vehicle accident and was transported to a MetroHealth medical center. According to the complaint, Tokmenko’s mother informed hospital staff that the plaintiff was deaf and relied primarily on American Sign Language (ASL). MetroHealth supplied Tomenko with pens and papers, whiteboards, and video relay interpreting equipment in order to aid communication, in addition to using Tokmenko’s mother and daughter as interpreters. Tokmenko states that these methods did not enable her to make informed medical decisions, and that her preference for American Sign Language and repeated requests for a professional ASL interpreter were ignored in violation of the Americans with Disabilities Act and the Affordable Care Act.
Tokmenko v. MetroHealth System
US District Court, ND Ohio, Eastern Division
Case No. 1:18CV2579
September 21, 2020
Christopher A. Boyko, Senior District Judge
“Mental healthcare is essential to a person’s overall health, and today, we reaffirmed that people must have access to care for mental health and addiction challenges.” —Senator Scott Wiener, California
[Editor’s note: This quote is from the above article Gov. Newsom signs package of bills addressing behavioral healthcare, Healthcare Innovation (09/25/2020) David Raths.]
CDC’s Public Health Law Program (PHLP) works to improve the health of the public by performing research, creating tools, and providing training to help practitioners understand and make law and policy decisions. Every month, PHLP publishes the Public Health Law News with announcements, legal tools, court opinions, job openings & more.
Subscribe!
Subscribe to Public Health Law News or access past issues. To make comments or suggestions, send an email message to PHLawProgram@cdc.gov.
Disclaimers
Public Health Law News (the News) content is selected solely on the basis of newsworthiness and potential interest to readers. CDC and HHS assume no responsibility for the factual accuracy of the items presented from other sources. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or HHS. Opinions expressed by the original authors of items included in the News, persons quoted therein, or persons interviewed for the News are strictly their own and are in no way meant to represent the opinion or views of CDC or HHS. References to products, trade names, publications, news sources, and non-CDC websites are provided solely for informational purposes and do not imply endorsement by CDC or HHS. Legal cases are presented for educational purposes only, and are not meant to represent the current state of the law. The findings and conclusions reported in this document are those of the author(s) and do not necessarily represent the views of CDC or HHS. The News is in the public domain and may be freely forwarded and reproduced without permission. The original news sources and the Public Health Law News should be cited as sources. Readers should contact the cited news sources for the full text of the articles.